Kidney and Gastro Issues Linked to Popular Pill to Get Thin

Jun 13th 2023 11:32pm EDT

STORY AT-A-GLANCE Semaglutide, the blockbuster drug being used for weight loss, is slated to bring in more than $10 billion in annual sales but serious adverse effects are emerging A study using data from Eudravigilance, Europe’s system for analyzing adverse reactions to medications, found a high prevalence of gastrointestinal disorders among users Other semaglutide patients […]

Discuss on Nostr!

Nostr Note ID note1kazhjnyqxtegqscxhqqsr76t8ar9k6czsuy6e0kwdjq7p03xd9gqvwefv8 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social

New to Nostr?
Create an account now & join the conversation!

Promote it on DissentWatch!

  • To advertise this post for $0.02 per visit send bitcoins to the address below
  • The post will be promoted daily via social media & our "Featured News" display in multiple places
  • You can add more anytime
  • Ranking order in the Featured News box is based on the balance remaining


Received: 0 mBTC (0.00 USD)

Spent: 0 mBTC (0.00 USD)

Balance: 0 mBTC (0.00 USD)

The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.

REFRESH AMOUNTS